Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended					6 Months Ended		12 Months Ended
	Mar. 01, 2024	Dec. 01, 2023	May 26, 2023	Feb. 24, 2023	Nov. 25, 2022	Mar. 01, 2024	Feb. 24, 2023	Aug. 25, 2023
Cash flows from operating activities
Net income (loss)	$ (13,007)	$ (19,360)		$ (26,786)	$ 5,324	$ (32,367)	$ (21,462)
Net income (loss) from discontinued operations	0			6,177		(8,148)	15,108
Net income (loss) from continuing operations	(13,007)			(32,963)		(24,219)	(36,570)
Adjustments to reconcile net loss from continuing operations to net cash provided by (used for) operating activities:
Depreciation expense and amortization of intangible assets						34,810	34,248
Amortization of debt discount and issuance costs						2,010	2,117
Share-based compensation expense	10,639			10,031		21,609	20,012
Impairment of goodwill	0			17,558		0	17,558
Change in fair value of contingent consideration	0			6,400		0	10,100
Loss (gain) on extinguishment or prepayment of debt	325		$ 16,700	16,691		325	15,924
Deferred income taxes, net						194	1,630
Other						456	4,116
Changes in operating assets and liabilities:
Accounts receivable						49,530	172,033
Inventories						2,214	10,240
Other assets						(21,127)	(9,893)
Accounts payable and accrued expenses and other liabilities						994	(174,745)
Payment of acquisition-related contingent consideration						(29,000)	(73,724)
Net cash provided by (used for) operating activities from continuing operations						37,796	(6,954)
Net cash provided by (used for) operating activities from discontinued operations						(28,235)	33,504
Net cash provided by (used for) operating activities						9,561	26,550
Cash flows from investing activities
Capital expenditures and deposits on equipment						(9,852)	(19,690)
Proceeds from maturities of investment securities						21,955	0
Purchases of held-to-maturity investment securities						(19,503)	0
Acquisition of business, net of cash acquired						0	(213,073)
Other						(746)	239
Net cash used for investing activities from continuing operations						(8,146)	(232,524)
Net cash provided by (used for) investing activities from discontinued operations						118,938	(4,472)
Net cash provided by (used for) investing activities						110,792	(236,996)
Cash flows from financing activities
Proceeds from debt						0	295,287
Proceeds from issuance of ordinary shares						4,247	4,250
Payment of acquisition-related contingent consideration						(21,000)	(28,100)
Payments to acquire ordinary shares						(15,862)	(16,223)
Repayments of debt						(51,634)	(7,211)
Payment of premium in connection with convertible note exchange						0	(14,141)
Net cash paid for settlement and purchase of Capped Calls						0	(4,304)
Distribution to noncontrolling interest						(1,470)	(2,009)
Other						(583)	(5,077)
Net cash provided by (used for) financing activities from continuing operations						(86,302)	222,472
Net cash used for financing activities from discontinued operations						(606)	(124)
Net cash provided by (used for) financing activities						(86,908)	222,348
Effect of changes in currency exchange rates						(1,180)	1,917
Net increase (decrease) in cash and cash equivalents						32,265	13,819
Cash and cash equivalents at beginning of period		$ 410,064	376,884		$ 363,065	410,064	363,065	$ 363,065
Cash and cash equivalents at end of period	442,329			376,884		442,329	376,884	$ 410,064
Continuing operations
Cash flows from financing activities
Cash and cash equivalents at beginning of period			310,377
Cash and cash equivalents at end of period	442,329			310,377		442,329	310,377
Discontinued operations
Cash flows from financing activities
Cash and cash equivalents at beginning of period			$ 66,507
Cash and cash equivalents at end of period	$ 0			$ 66,507		$ 0	$ 66,507